JP2017512838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512838A5 JP2017512838A5 JP2017502946A JP2017502946A JP2017512838A5 JP 2017512838 A5 JP2017512838 A5 JP 2017512838A5 JP 2017502946 A JP2017502946 A JP 2017502946A JP 2017502946 A JP2017502946 A JP 2017502946A JP 2017512838 A5 JP2017512838 A5 JP 2017512838A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- seq
- antibody
- isolated antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2014074199 | 2014-03-27 | ||
| CNPCT/CN2014/074199 | 2014-03-27 | ||
| CN2014081797 | 2014-07-08 | ||
| CNPCT/CN2014/081797 | 2014-07-08 | ||
| PCT/US2015/023108 WO2015148984A2 (en) | 2014-03-27 | 2015-03-27 | Antibodies that bind human cannabinoid 1 (cb1) receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017512838A JP2017512838A (ja) | 2017-05-25 |
| JP2017512838A5 true JP2017512838A5 (OSRAM) | 2018-05-17 |
| JP6598844B2 JP6598844B2 (ja) | 2019-10-30 |
Family
ID=53008849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502946A Active JP6598844B2 (ja) | 2014-03-27 | 2015-03-27 | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US10308712B2 (OSRAM) |
| EP (2) | EP3122780B1 (OSRAM) |
| JP (1) | JP6598844B2 (OSRAM) |
| KR (2) | KR102553870B1 (OSRAM) |
| CN (1) | CN106232626B (OSRAM) |
| AU (1) | AU2015237275B2 (OSRAM) |
| CA (1) | CA2944049A1 (OSRAM) |
| CL (3) | CL2016002433A1 (OSRAM) |
| ES (1) | ES2915101T3 (OSRAM) |
| IL (1) | IL248006B2 (OSRAM) |
| MA (1) | MA39708A (OSRAM) |
| MX (1) | MX2016012403A (OSRAM) |
| PE (1) | PE20170258A1 (OSRAM) |
| RU (1) | RU2730674C2 (OSRAM) |
| TW (1) | TWI694086B (OSRAM) |
| WO (1) | WO2015148984A2 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6598844B2 (ja) * | 2014-03-27 | 2019-10-30 | バード・ロック・バイオ・インコーポレイテッド | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
| JP2019502651A (ja) * | 2015-09-30 | 2019-01-31 | バード・ロック・バイオ・インコーポレイテッドＢｉｒｄ Ｒｏｃｋ Ｂｉｏ， Ｉｎｃ． | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
| MX2019014577A (es) | 2017-06-05 | 2020-07-29 | Janssen Biotech Inc | Anticuerpos que se unen especificamente a pd-1 y metodos de uso. |
| US11091545B2 (en) | 2017-07-13 | 2021-08-17 | Kyowa Kirin Co., Ltd. | Methods of using an antibody to stabilize and analyze a BRIL fusion protein |
| CN108588071A (zh) * | 2018-04-25 | 2018-09-28 | 和元生物技术（上海）股份有限公司 | CRISPR-Cas9靶向敲除人肠癌细胞CNR1基因及其特异性的sgRNA |
| CN112218684A (zh) * | 2018-04-30 | 2021-01-12 | 武田药品工业株式会社 | 大麻素受体1型(cb1)结合蛋白及其用途 |
| WO2020018554A1 (en) * | 2018-07-17 | 2020-01-23 | The Regents Of The University Of California | Methods of treating renal disease |
| US12435131B2 (en) | 2019-07-11 | 2025-10-07 | Tavotek Biotherapeutics (Hong Kong) Limited | Agents that interfere with thymic stromal lymphopoietin (TSLP)-receptor signaling |
| CA3247425A1 (en) * | 2022-04-04 | 2023-10-12 | Bird Rock Bio Sub Inc | PREDICTION AND TREATMENT OF RAPIDLY PROGRESS KIDNEY DISEASE |
| JPWO2023234406A1 (OSRAM) | 2022-06-03 | 2023-12-07 | ||
| WO2024022478A1 (zh) * | 2022-07-28 | 2024-02-01 | 长春金赛药业有限责任公司 | 结合大麻素受体cb1的抗体及其用途 |
| WO2024212999A1 (zh) * | 2023-04-11 | 2024-10-17 | 微境生物医药科技(上海)有限公司 | Cbl-b抑制剂 |
| CN118027211A (zh) * | 2024-04-11 | 2024-05-14 | 上海惠盾因泰生物科技有限公司 | 一种识别重组egf-crm197疫苗的单克隆抗体及其应用 |
| CN120647762A (zh) * | 2025-06-16 | 2025-09-16 | 首都医科大学附属北京友谊医院 | 一种抗β1-AR-ECII抗体及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466579A (en) | 1987-12-28 | 1995-11-14 | Psychemedics Corporation | Hair analysis method |
| US5460785A (en) | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5817766A (en) | 1995-04-05 | 1998-10-06 | Roche Diagnostic Systems, Inc. | Reagents for a cannabinoid immunoassay |
| US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| DK1272647T3 (en) | 2000-04-11 | 2014-12-15 | Genentech Inc | Multivalent antibodies and uses thereof |
| US7214786B2 (en) | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| US8420353B2 (en) | 2002-03-22 | 2013-04-16 | Aprogen, Inc. | Humanized antibody and process for preparing same |
| US7754188B2 (en) | 2003-06-30 | 2010-07-13 | Merck Sharp & Dohme Corp. | Radiolabeled cannabinoid-1 receptor modulators |
| US20050095674A1 (en) | 2003-07-23 | 2005-05-05 | Lewis Deborah L. | Cannabinoid receptor interacting proteins and methods of use |
| WO2005023232A2 (en) * | 2003-09-04 | 2005-03-17 | Affibody Ab | Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| EP1574211A1 (en) | 2004-03-09 | 2005-09-14 | Inserm | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| ITMI20041033A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Composti farmaceutici |
| WO2006047417A2 (en) | 2004-10-21 | 2006-05-04 | University Of Florida Research Foundation, Inc. | Detection of cannabinoid receptor biomarkers and uses thereof |
| WO2006129193A2 (en) | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| TWI323734B (en) | 2005-08-19 | 2010-04-21 | Abbott Lab | Dual variable domain immunoglobulin and uses thereof |
| US8460362B2 (en) | 2006-07-20 | 2013-06-11 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| WO2008048648A2 (en) | 2006-10-17 | 2008-04-24 | Acadia Pharmaceuticals Inc. | Cb1-modulating compounds and their use |
| WO2008147518A1 (en) | 2007-05-23 | 2008-12-04 | Merck & Co., Inc. | Pyridyl piperidine orexin receptor antagonists |
| KR101603917B1 (ko) | 2008-05-09 | 2016-03-17 | 애브비 인코포레이티드 | 최종 당화 산물의 수용체(ｒａｇｅ)에 대한 항체 및 이의 용도 |
| FI20085579A0 (fi) | 2008-06-12 | 2008-06-12 | Valtion Teknillinen | Kannabiskäytön toteaminen |
| IT1394400B1 (it) * | 2009-02-25 | 2012-06-15 | Neuroscienze Pharmaness S C Ar L | Composizioni farmaceutiche |
| JP5812418B2 (ja) | 2009-04-17 | 2015-11-11 | イムナス・ファーマ株式会社 | Ａβオリゴマーに特異的に結合する抗体およびその利用 |
| EA029400B1 (ru) * | 2010-07-15 | 2018-03-30 | Олег Ильич ЭПШТЕЙН | Фармацевтическая композиция для лечения ожирения и сопутствующих метаболических расстройств и способ лечения |
| WO2012088302A2 (en) | 2010-12-22 | 2012-06-28 | Abbott Laboratories | Half immunoglobulin binding proteins and uses thereof |
| WO2012088290A2 (en) | 2010-12-22 | 2012-06-28 | Abbott Laboratories | Tri-variable domain binding proteins and uses thereof |
| US9435817B2 (en) | 2011-02-14 | 2016-09-06 | Randox Laboratories Limited | Detection of synthetic cannabinoids |
| GB201102544D0 (en) | 2011-02-14 | 2011-03-30 | Randox Lab Ltd | Assay |
| US9441033B2 (en) | 2011-02-14 | 2016-09-13 | Randox Laboratories Limited | Detection of synthetic cannabinoids |
| BR112013029673B1 (pt) | 2011-05-20 | 2021-11-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antagonistas de receptor de cb1 |
| US8758826B2 (en) | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
| EP2698383B1 (en) | 2012-08-14 | 2020-11-25 | Randox Laboratories Ltd. | Detection of synthetic Cannabinoids |
| AU2014302410B2 (en) * | 2013-06-26 | 2019-06-13 | Amgen Inc. | CB1 receptor antigen-binding proteins and uses thereof |
| JP2017500028A (ja) | 2013-12-12 | 2017-01-05 | アッヴィ・ステムセントルクス・エル・エル・シー | 新規の抗ｄｐｅｐ３抗体および使用方法 |
| JP6598844B2 (ja) * | 2014-03-27 | 2019-10-30 | バード・ロック・バイオ・インコーポレイテッド | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
-
2015
- 2015-03-27 JP JP2017502946A patent/JP6598844B2/ja active Active
- 2015-03-27 KR KR1020167029997A patent/KR102553870B1/ko active Active
- 2015-03-27 PE PE2016001719A patent/PE20170258A1/es unknown
- 2015-03-27 CN CN201580015645.5A patent/CN106232626B/zh active Active
- 2015-03-27 IL IL248006A patent/IL248006B2/en unknown
- 2015-03-27 TW TW104110160A patent/TWI694086B/zh active
- 2015-03-27 EP EP15719033.1A patent/EP3122780B1/en active Active
- 2015-03-27 US US14/774,582 patent/US10308712B2/en active Active
- 2015-03-27 EP EP22160342.6A patent/EP4159761A1/en active Pending
- 2015-03-27 MA MA039708A patent/MA39708A/fr unknown
- 2015-03-27 WO PCT/US2015/023108 patent/WO2015148984A2/en not_active Ceased
- 2015-03-27 MX MX2016012403A patent/MX2016012403A/es unknown
- 2015-03-27 RU RU2016141919A patent/RU2730674C2/ru active
- 2015-03-27 AU AU2015237275A patent/AU2015237275B2/en active Active
- 2015-03-27 CA CA2944049A patent/CA2944049A1/en active Pending
- 2015-03-27 KR KR1020237022858A patent/KR102731863B1/ko active Active
- 2015-03-27 ES ES15719033T patent/ES2915101T3/es active Active
-
2016
- 2016-09-27 CL CL2016002433A patent/CL2016002433A1/es unknown
-
2019
- 2019-01-25 US US16/257,511 patent/US11566069B2/en active Active
- 2019-03-27 CL CL2019000799A patent/CL2019000799A1/es unknown
-
2021
- 2021-10-08 CL CL2021002637A patent/CL2021002637A1/es unknown
-
2023
- 2023-01-27 US US18/160,745 patent/US20230348589A1/en not_active Abandoned
-
2024
- 2024-10-08 US US18/909,574 patent/US20250236669A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017512838A5 (OSRAM) | ||
| RU2016141919A (ru) | Антитела, связывающиеся с человеческим каннабиноидным рецептором 1 (св1) | |
| JP6681433B2 (ja) | Ｐ２ｘ７受容体アンタゴニスト及びアゴニスト | |
| AU2018312222B2 (en) | Anti-CD47 antibodies and uses thereof | |
| JP7273110B2 (ja) | 高親和性抗ｖｅｇｆ抗体 | |
| JP2020501531A5 (OSRAM) | ||
| JP2017526370A5 (OSRAM) | ||
| JP2012501669A5 (OSRAM) | ||
| JP2008516970A5 (OSRAM) | ||
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 | |
| JP2012501670A5 (OSRAM) | ||
| JP2014500009A5 (OSRAM) | ||
| JP2013502913A5 (OSRAM) | ||
| JP2015530971A5 (OSRAM) | ||
| JP2010526028A5 (OSRAM) | ||
| JP2015533853A5 (OSRAM) | ||
| JP2011207882A5 (OSRAM) | ||
| JP2017505622A5 (OSRAM) | ||
| JP2013538057A5 (OSRAM) | ||
| JP2011520898A5 (OSRAM) | ||
| JP2022507679A (ja) | Ｈｅｒ２／ｐｄ１二重特異性抗体 | |
| JP2014524733A5 (OSRAM) | ||
| TWI869528B (zh) | C5ar1抗體分子及其用途 | |
| WO2011094465A4 (en) | Methods of treating autoimmune diseases with dll4 antagonists | |
| US20240101675A1 (en) | Dual binding antibodies, methods of producing dual binding antibodies, and uses thereof |